Rituxan

Latest stories

18h
Business Wire
Genentech Highlights Personalized Medicines and Cancer Immunotherapies at 2016 American Society of Clinical Oncology (ASCO) Annual Meetingof one prior treatment with a chemotherapy. Results for Genentech’s hematology
Genentech Highlights Personalized Medicines and Cancer Immunotherapies at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting
Business Wire / Posted 18 hours ago
of one prior treatment with a chemotherapy. Results for Genentech’s hematology medicines include data from a study of Rituxan® (rituximab) in children with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL). Results... Read more
6d
FOX Business
Exelixis, Inc. vs. Rochesales rose about 4% at a constant exchange rate to about $12.7 billion.Sales gr
Exelixis, Inc. vs. Roche
FOX Business / Posted 6 days ago
sales rose about 4% at a constant exchange rate to about $12.7 billion.Sales growth of its three top-selling products -- Rituxan, Herceptin, and Avastin -- has slowed low single-digits, but the three still produced combined sales of about $5.4... Read more
6d
FOX Business
Exelixis, Inc. vs. Rochesales rose about 4% at a constant exchange rate to about $12.7 billion.Sales gr
Exelixis, Inc. vs. Roche
FOX Business / Posted 6 days ago
sales rose about 4% at a constant exchange rate to about $12.7 billion.Sales growth of its three top-selling products -- Rituxan, Herceptin, and Avastin -- has slowed low single-digits, but the three still produced combined sales of about $5.4... Read more
12d
Business Wire
Biogen Reports First Quarter 2016 Revenues of $2.7 Billionchemotherapy followed by Gazyva alone as a new treatment for people with follic
Biogen Reports First Quarter 2016 Revenues of $2.7 Billion
Business Wire / Posted 12 days ago
chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma who did not respond to a Rituxan®-containing regimen, or had their follicular lymphoma return after such treatment. Follicular lymphoma is the most... Read more
18d
San Antonio Express-News
15 Reasons to Buy Pfizer and Never Sellexpected to take market share from some of the biggest blockbusters. We're talk
15 Reasons to Buy Pfizer and Never Sell
San Antonio Express-News / Posted 18 days ago
expected to take market share from some of the biggest blockbusters. We're talking about cancer drugs Herceptin, Avastin, Rituxan and Neulasta, as well as the best-selling drug in the world, Humira. Biosimilars could be a major growth driver for... Read more
18d
Boston Globe
Boston Medical Center to pay $1.1m for Medicare, Medicaid fraudhospital and two of its physician groups were charged with billing Medicare for
Boston Medical Center to pay $1.1m for Medicare, Medicaid fraud
Boston Globe / Posted 18 days ago
hospital and two of its physician groups were charged with billing Medicare for more units of the cancer drug Rituxan than it actually used, billing Medicare and Medicaid for services at a presurgical center that were covered by other... Read more
2 related stories
19d
WLOX-TV Biloxi
The Most Dangerous DrugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The Most Dangerous Drugs
WLOX-TV Biloxi / Posted 19 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
19d
KPLC Lake Charles
The Most Dangerous DrugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The Most Dangerous Drugs
KPLC Lake Charles / Posted 19 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
20d
WTKR Norfolk
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
WTKR Norfolk / Posted 20 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
20d
Q13 FOX Seattle
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
Q13 FOX Seattle / Posted 20 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
20d
FOX 13 Utah
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
FOX 13 Utah / Posted 20 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
20d
CBS 6 Richmond
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
CBS 6 Richmond / Posted 20 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
21d
FOX 6 Milwaukee
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
FOX 6 Milwaukee / Posted 21 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
21d
FOX 2 News St. Louis
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
FOX 2 News St. Louis / Posted 21 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
21d
KPLR 11 St. Louis
The 20 most dangerous drugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 most dangerous drugs
KPLR 11 St. Louis / Posted 21 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
21d
FOX40 Sacramento
The 20 Most Dangerous DrugsReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
The 20 Most Dangerous Drugs
FOX40 Sacramento / Posted 21 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
21d
WFLX FOX 29
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
WFLX FOX 29 / Posted 21 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan#3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
21d
WRTV Indianapolis
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
WRTV Indianapolis / Posted 21 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
22d
NBC26 Green Bay
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
NBC26 Green Bay / Posted 22 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
22d
KIVI Boise
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
KIVI Boise / Posted 22 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
22d
KGTV San Diego
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
KGTV San Diego / Posted 22 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
22d
KMGH 7 Denver
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
KMGH 7 Denver / Posted 22 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
22d
ABC Action News Tampa Bay
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
ABC Action News Tampa Bay / Posted 22 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
22d
KTNV Las Vegas
These are the 50 most dangerous drugs on the marketReactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Clas
These are the 50 most dangerous drugs on the market
KTNV Las Vegas / Posted 22 days ago
Reactions: 30,014 Total Number of Reported Reactions: 31,157 Therapeutic Class: Antineoplastic Agent Brand Names: Rituxan #3. Bevacizumab Percent of Reactions That Were Serious: 96% Number of Serious Reactions: 39,957 Total Number of... Read more
19 related stories
23d
Investopedia
VTIAX: Vanguard International Stock Fund's Top 5 Holdings AnalysisThe pharmaceutical segment accounted for 78% of Roche's total 2015 sales, led b
VTIAX: Vanguard International Stock Fund's Top 5 Holdings Analysis
Investopedia / Posted 23 days ago
The pharmaceutical segment accounted for 78% of Roche's total 2015 sales, led by drugs such as Avastin, Herceptin and Rituxan. The major pharmaceutical categories in which the company specializes are oncology, immunology, infectious diseases,... Read more
27d
The Economic Times
FDA approves biosimilar to J&J's Remicade for multiple diseasesto apply for global approval in the second half of this year, and its copy of R
FDA approves biosimilar to J&J's Remicade for multiple diseases
The Economic Times / Posted 27 days ago
to apply for global approval in the second half of this year, and its copy of Roche's non-Hodgkin's lymphoma biotech drug Rituxan, also called MabThera, is currently awaiting European approval after applying in October. Shares in Celltrion were... Read more
4 related stories
1m
MedCity News
Is the time right for digital therapeutics? 5 must-read stories from MedCity News this weekfor Humira (adalimumab), and Aprogen filed two drugs – G5071, which mimics Remi
Is the time right for digital therapeutics? 5 must-read stories from MedCity News this week
MedCity News / Posted a month ago
for Humira (adalimumab), and Aprogen filed two drugs – G5071, which mimics Remicade (infliximab) and AP052, which mimics Rituxan (rituximab). Many more are in late stage development, and should make it to market in time for these drugs to go... Read more

People in this news